Aim: We aimed to assess economic burden of breast cancer (BC) diagnosis and treatment in China through a multicenter cross-sectional study, and to obtain theoretical evidence for policy-making.
Methods: This survey was conducted in 37 hospital centers across 13 provinces in China from September 2012 to December 2014. We collected information on the subject characteristics. We then assessed the medical and non-medical expenditure for BC diagnosis and treatment, factors influencing the average case expense, variations between medical and non-medical expenditure at different clinical stages, economic impact of overall expenditure in newly diagnosed course after reimbursement to the patient's family, composition of non-medical expenditure and time loss for the patient and family.
Results: Among 2746 women with BC (72.6% were admitted to specialized hospitals), the overall average expenditure was US $8450 (medical expenditure: $7527; non-medical expenditure: $922). Significant differences were found among the overall expenditure in the four clinical stages (P < 0.0001); the expenditure was higher in stages III and IV than that in stages I and II, whereas the stage IV was the highest (P < 0.0001). Moreover, a higher self-reported predicted reimbursement ratio was associated with a less economic impact on the patient's family, and the average time lost was estimated as $1529.
Conclusions: Early detection and treatment of breast cancer might be effective for decreasing the economic burden, because costs escalate as the degree of malignancy increases.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ajco.12703 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cost of TB care and equity in distribution of catastrophic TB care costs across income quintiles in India.
Glob Health Res Policy
December 2024
ICMR-National Institute of Epidemiology (ICMR-NIE), R-127, TNHB, Ayapakkam, Chennai, Tamil Nadu, 600077, India.
Background: Tuberculosis (TB) poses a significant social and economic burden to households of persons with TB (PwTB). Despite free diagnosis and care under the National TB Elimination Programme (NTEP), individuals often experience significant out-of-pocket expenditure and lost productivity, causing financial catastrophe. We estimated the costs incurred by the PwTB during TB care and identified the factors associated with the costs.
View Article and Find Full Text PDFThe economic burden of leprosy treatment to households in Ghana: A cross-sectional study in the Volta Region of Ghana.
SAGE Open Med
November 2024
Ankaful Leprosy and General Hospital, Cape Coast, Ghana.
Background: Despite the known detrimental socio-economic consequences of leprosy morbidity, disability and social exclusion at the household level, research investigating the precise economic burden of leprosy remains scarce. This study aims to address this gap by examining the socio-economic burden of leprosy in Ho municipality in the Volta Region of Ghana.
Methods: This was a cross-sectional cost of illness study, and quantitative data were collected from leprosy patients between October and December 2023.
Out-of-pocket payment and catastrophic health expenditure of tuberculosis patients in accessing care at public-private mix clinics in Myanmar, 2022.
Infect Dis Poverty
November 2024
Population Services International Myanmar, Yangon, Myanmar.
Article Synopsis
- - The study examined the financial burden of tuberculosis (TB) on patients in Myanmar, particularly those utilizing private providers in public-private mix (PPM) schemes, despite TB services being generally free.
- - A survey of 695 adults revealed that patients incurred a median total cost of approximately $53.4 for TB treatment, with the most significant expenses occurring during the pre-treatment phase and clinic visits.
- - Alarmingly, about 34.5% of patients faced catastrophic health expenditure, defined as spending over 20% of their financial capacity on TB-related costs, highlighting the ongoing economic challenges despite available healthcare services.
Cost effectiveness and return on investment analysis for surgical care in a conflict-affected region of Sudan.
PLOS Glob Public Health
November 2024
Department of Surgery, Duke University School of Medicine, Durham, North Carolina, United States of America.
The delivery of healthcare in conflict-affected regions places tremendous strains to health systems, and the economic value of surgical care in conflict settings remains poorly understood. Our aims were to evaluate the cost-effectiveness, societal economic benefits, and return on investment (ROI) for surgical care in a conflict-affected region in Sudan. We conducted a retrospective study of surgical care from January to December 2022 at the Mother of Mercy-Gidel Hospital (MMH) in the Nuba Mountains of Sudan, a semi-autonomous region characterized by chronic and cyclical conflict.
View Article and Find Full Text PDFTechnical efficiency analysis of advanced medical centers in Burkina Faso.
BMC Health Serv Res
October 2024
FERDI (Fondation pour les Etudes et Recherches sur le Développement International - Foundation for Studies and Research on International Development), Clermont-Ferrand, France.
Article Synopsis
- Burkina Faso's health system suffers from limited public health funds, highlighting the need for efficiency in health spending among its Advanced Medical Centers (AMCs) from 2017 to 2020.
- The study utilized bootstrap Data Envelopment Analysis (DEA) to evaluate 45 AMCs, revealing an average efficiency score of 0.51, which suggests that these centers could nearly double their healthcare outputs without extra resources.
- Key factors influencing AMC efficiency included the population's size, education, health status, and the density of healthcare services, emphasizing the importance of optimizing resource allocation within the health policy framework.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!